Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Vinko, Bogdanić"'
Autor:
Jasminka Jakić-Razumović, Mirando Mrsić, Smilja Kalenić, Boris Labar, Vinko Bogdanić, Damir Nemet, Marija Jandrlić, Vanda Plečko
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 14:768-774
The aim of this study was to determine the incidence of fungal infections detected on autopsy in a group of 40 patients with hematologic malignancies treated with intensive chemotherapy or bone marrow transplantation, and to evaluate the risk factors
Autor:
Marijo Vodanović, Ranka Serventi-Seiwerth, Dubravka Sertić, Sanja Davidović, Renato Zadro, Vinko Bogdanić, Dražen Pulanić, Boris Labar
Publikováno v:
Medicina Fluminensis : Medicina Fluminensis
Volume 47
Issue 4
Volume 47
Issue 4
Cilj: U radu je prikazan slučaj bolesnika s Philadelphia pozitivnom kroničnom mijeloičnom leukemijom koji je liječen imatinibom zbog relapsa nakon transplantacije alogenih krvotvornih matičnih stanica. Prikaz slučaja: Deset godina nakon alogene
Autor:
Mirando, Mrsić, Ranka Serventi, Seiwerth, Boris, Labar, Vinko, Bogdanić, Damir, Nemet, N, Duraković, M, Mikulić, Dubravka, Sertić, Igor, Aurer, I, Radman, Silva, Zupancić-Salek
Publikováno v:
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti. 63(3)
Aplastic anemia is a bone marrow disease characterized by marrow aplasia and pancytopenia. Because hematopoietic stem cell transplantation (HSCT) cures severe aplastic anemia (SAA), it is the treatment of choice for younger patients. For many years,
Autor:
Ranka Serventi, Seiwerth, Mirando, Mrsić, Damir, Nemet, Vinko, Bogdanić, Mirta, Mikulić, Dubravka, Sertić, Lana, Grković, Esma, Cecuk, Ines, Bojanić, Drago, Batinić, Boris, Labar
Publikováno v:
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti. 63(3)
Allogeneic hematopoietic stem cell transplantation is a standard therapeutic option in the treatment of patients with malignant hematologic diseases and some acquired or inherited nonmalignant hematologic disorders. It is the most efficacious method
Autor:
Dubravka, Zupanić-Krmek, Damir, Nemet, Mirando, Mrsić, Vinko, Bogdanić, Boris, Labar, Marija, Jandrlić, Smilja, Kalenić
Publikováno v:
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti. 58(4)
The incidence, outcome and risk factors for developing invasive fungal infection were retrospectively analyzed in 150 patients with acute leukemia during intensive cytostatic therapy.Patients with and without the diagnosis of fungal infection were co
Autor:
Igor Aurer, Mirando Mrsić, Damir Nemet, Boris Labar, Silva Zupančić-Šalek, Dubravka Sertić, Ivo Radman, Vinko Bogdanić
Patients with refractory Hodgkin's disease or relapsing after high-dose therapy and autografting have a poor prognosis. Here, we present our experiences with gemcitabine in this setting.We treated 14 patients with relapsed or refractory Hodgkin's dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a689c7fb3240962142484c804fcd4f
https://www.bib.irb.hr/234488
https://www.bib.irb.hr/234488
Autor:
Josko, Bulum, Boris, Labar, Mirta, Mikulić, Vinko, Bogdanić, Dubravka, Sertić, Damir, Nemet, Velka, Krecak-Gverić, Jasna, Kovacević, Ranka, Serventi-Seiwerth, Sanja, Mrsić-Davidović, Renata, Zadro, Dubravka, Boban
Publikováno v:
Lijecnicki vjesnik. 125(7-8)
Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), in advanced stage of disease, is resistant to standard chemotherapy. Imatinib was found to be effective in these patients. This paper shows our preliminary results. Imatinib mesylat
Autor:
Mirando, Mrsić, Ana, Stavljenić-Rukavina, Ksenija, Fumić, Boris, Labar, Vinko, Bogdanić, Kristina, Potocki, Ika, Kardum-Skelin, Diana, Rovers
Publikováno v:
Croatian medical journal. 44(5)
To evaluate the feasibility of financing the treatment of Gaucher disease with recombinant human imiglucerase in the Croatian health care system.Treatment with enzyme replacement therapy of 5 patients with Gaucher disease was started on January 2001.
Publikováno v:
Acta Haematologica. 92:123-125
RAS mutations are found in about 25% of acute myeloid leukemia (AML) cases. The importance of these changes is unknown. If RAS mutations confer growth advantage to leukemia subclones in which they emerge, substantially more nonconservative than conse
Autor:
Ivo, Radman, Jasminka, Kovacević-Metelko, Igor, Aurer, Damir, Nemet, Silva, Zupancić-Salek, Vinko, Bogdanić, Dubravka, Sertić, Mirando, Mrsić, Roland, Pulanić, Vladimir, Gasparović, Boris, Labar
Publikováno v:
Croatian medical journal. 43(5)
To evaluate the role of surgical resection in the treatment of patients with primary gastrointestinal non-Hodgkin s lymphoma in our institution.The retrospective study included 79 patients with a histologically confirmed primary gastrointestinal lymp